Skip to content

Promoting Physical Activity in Patients With Type 2 Diabetes (DIAfit)

Efficacy and Feasibility of a Program to Promote Physical Activity in Patients With Type 2 Diabetes (DIAfit)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01289587
Acronym
DIAfit
Enrollment
185
Registered
2011-02-04
Start date
2011-02-28
Completion date
2017-10-31
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

Diabetes, Physical activity, Body composition, Aerobic fitness, Metabolic control

Brief summary

The aim of this study is to evaluate the effects of a physical activity intervention in patients with type 2 diabetes in a community setting.

Detailed description

The aim of this study is 1. to evaluate the effects (before and after) of a physical activity program (DIAfit program) which contains 36 sessions of structured PA and also encourages unstructured PA in an unselected population of patients with type 2 diabetes independent of the selected variant of the program 2. to compare the effects of a standard DIAfit program (3 times per week for 12 weeks) with and alternative program which suggests a more progressive PA activity intensity (starting with one PA session per week during 4 weeks and then twice a week over a period of 16 more weeks (20 weeks total). In total the program also consist of 36 sessions)

Interventions

BEHAVIORALPhysical activity intervention

36 sessions of physical activity offered at different frequencies

Sponsors

University Hospital, Geneva
CollaboratorOTHER
University of Lausanne Hospitals
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of type 2 diabetes

Exclusion criteria

* Orthopedic complications * Diabetic foot ulceration * Active cardiac (ischemia during the exercise test) or stade III peripheral vascular disease * Untreated proliferative retinopathy * Autonomic neuropathy * Active psychiatric, neurological, orthopedic, muscular or rheumatic disease interfering with a participation in a physical activity program * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Aerobic fitnessEnd of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)Change in aerobic fitness

Secondary

MeasureTime frameDescription
BMIAt the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)Change in BMI
HbA1cAt the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)Change in HbA1c
Lipid valuesAt the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)Change in Lipid values
Motor performanceAt the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)Change in motor performance
Body compositionAt the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)Change in body composition
Well-beingAt the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)Change in well-being (validated questionnaire)
Self-efficacyAt the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)Change in self-efficacy (questionnaire)
Qualitative evaluation (satisfaction of achievement of personal objectives, evaluation of group session)At the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)
Adherence/Attendance: Number of physical activity sessions attendedDuring the intervention
Physical activityAt the end of the intervention (36 PA sessions, 12 vs 20 weeks depending on assignment)Change in physical activity

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026